好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Structure-function Correlates in Myelin Oligodendrocyte Glycoprotein Antibody Disease Optic Neuritis
Neuro-ophthalmology/Neuro-otology
P7 - Poster Session 7 (11:45 AM-12:45 PM)
10-004

To characterize longitudinal focal optical coherence tomography (OCT) and visual function abnormalities in myelin oligodendrocyte glycoprotein (MOG) optic neuritis (ON).

MOG antibody disease is a demyelinating disorder that most commonly presents with optic neuritis (ON), and affects children more often than adults.

This is a retrospective case series of eight young patients with MOG-associated ON (MOG titer ≥1:100) who were referred for neuro-ophthalmic evaluation. Data for history, physical exam, and OCT obtained in the course of clinical evaluations were collected via medical record review. Stata statistical software was used to calculate Spearman correlations between visual function and OCT parameters.

Patients demonstrated acute peripapillary retinal nerve fiber layer (RNFL) thickening followed by steady RNFL thinning, with 9/16 and 11/16 eyes reaching significantly low RNFL thickness and papillomacular bundle (PMB) thickness, respectively (P<0.01). Concurrently, there was recovery of high-contrast visual acuity (HCVA) in all 5 affected eyes without recovery of contrast sensitivity (CS) in all but 1 of 11 affected eyes. There was no correlation between HCVA and OCT measures. By contrast, lower global RNFL thickness was associated with worse CS (rs=+0.36) and visual field depression (rs=+0.66). Lower PMB thickness was associated with worse CS, color vision by Ishihara plates, and visual field depression (rs=+0.42, +0.41, +0.38, respectively). Higher nasal/temporal ratio was associated with worse CS and less visual field depression (rs=-0.42, +0.48, respectively).

MOG shows a pattern of prominent retinal atrophy, as demonstrated by global RNFL thinning, with remarkable preservation of HCVA but concurrent deficits in CS, color vision, and visual fields. These tests may be better clinical markers of vision changes secondary to MOG-ON. Of the OCT parameters measured, PMB thickness demonstrated the most consistent correlation between structural and functional measures. Thus, it may be a more sensitive marker of clinically significant retinal atrophy in MOG-ON than global RNFL thickness.

Authors/Disclosures
Kimberly O'Neill, MD
PRESENTER
Dr. O'Neill has nothing to disclose.
Ruby Ross, MD (NYU Grossman School of Medicine) Ms. Ross has nothing to disclose.
Rachel Kenney Rachel Kenney has received personal compensation for serving as an employee of Optum. Rachel Kenney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minton 好色先生 LLC.
Laura J. Balcer, MD, MSCE, FAAN (NYU Grossman School of Medicine) An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Steven Galetta, MD, FAAN (NYU Langone Medical Center) Dr. Galetta has nothing to disclose.
Lauren B. Krupp, MD, FAAN (NYU Langone Medical Center) Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Christina Marini Ms. Marini has nothing to disclose.
Scott Grossman, MD (New York University, Langone Health) Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.